Literature DB >> 1472481

Signaling function of reconstituted CD16: zeta: gamma receptor complex isoforms.

E Vivier1, N Rochet, M Ackerly, J Petrini, H Levine, J Daley, P Anderson.   

Abstract

Natural killer cells express an Fc receptor for IgG (CD16) in association with disulfide-linked dimers composed of two homologous subunits: the zeta chain of the T cell antigen receptor complex and the gamma chain of the mast cell/basophil Fc receptor for IgE. The ability of zeta and gamma to transduce CD16-mediated activation signals was compared by reconstituting distinct CD16 receptor isoforms composed of various combinations of zeta- and gamma-containing dimers. Stably transformed non-hematopoietic and hematopoietic cell lines were established that expressed chimeric molecules comprising the extracellular domain of CD16 joined to the transmembrane and intracellular domains of zeta or gamma. Reconstituted CD16 receptor complexes triggered Ca2+ influx, tyrosine phosphorylation, and IL-2 production in stable transformants of the Jurkat T cell line. However, cross-linking of the CD16/gamma chimera induced a specific pattern of tyrosine phosphorylation and was more efficient at signal transduction than a CD16, zeta-zeta complex, suggesting that zeta and gamma cytoplasmic domains may be coupled to distinct tyrosine kinase pathways that differentially regulate CD16-mediated activation signals. By contrast, both CD16/zeta and CD16/gamma chimeric molecules were not functional in stable transformants of the fibroblast Chinese Hamster Ovary cell line, indicating a requirement for downstream signaling components present in hematopoietic cells. Finally, the zeta transmembrane domain appears to preferentially associate with CD16 rather than the CD3:TCR complex, suggesting that a hierarchy of molecular interactions governs NK and T cell differentiation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1472481     DOI: 10.1093/intimm/4.11.1313

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  12 in total

1.  Identification of human NK cells that are deficient for signaling adaptor FcRγ and specialized for antibody-dependent immune functions.

Authors:  Ilwoong Hwang; Tianxiang Zhang; Jeannine M Scott; Ae Ra Kim; Taehyung Lee; Tejaswi Kakarla; Ahrom Kim; John B Sunwoo; Sungjin Kim
Journal:  Int Immunol       Date:  2012-09-07       Impact factor: 4.823

Review 2.  Optimizing intracellular signaling domains for CAR NK cells in HIV immunotherapy: a comprehensive review.

Authors:  Giorgio Zenere; Omalla Allan Olwenyi; Siddappa N Byrareddy; Stephen E Braun
Journal:  Drug Discov Today       Date:  2019-02-13       Impact factor: 7.851

3.  Human recombinant anti-thyroperoxidase autoantibodies: in vitro cytotoxic activity on papillary thyroid cancer expressing TPO.

Authors:  S A Rebuffat; M Morin; B Nguyen; F Castex; B Robert; S Péraldi-Roux
Journal:  Br J Cancer       Date:  2010-02-09       Impact factor: 7.640

4.  The human natural killer cytotoxic cell line NK-92, once armed with a murine CD16 receptor, represents a convenient cellular tool for the screening of mouse mAbs according to their ADCC potential.

Authors:  Béatrice Clémenceau; Régine Vivien; Catherine Pellat; Michael Foss; Gilles Thibault; Henri Vié
Journal:  MAbs       Date:  2013-05-29       Impact factor: 5.857

5.  Downregulation of CD3ζ in NK Cells from Systemic Lupus Erythematosus Patients Confers a Proinflammatory Phenotype.

Authors:  Abel Suárez-Fueyo; Sean J Bradley; Takayuki Katsuyama; Sarah Solomon; Eri Katsuyama; Vasileios C Kyttaris; Vaishali R Moulton; George C Tsokos
Journal:  J Immunol       Date:  2018-03-30       Impact factor: 5.422

6.  Enhancing production and cytotoxic activity of polymeric soluble FasL-based chimeric proteins by concomitant expression of soluble FasL.

Authors:  Aurore Morello; Sophie Daburon; Michel Castroviejo; Jean-François Moreau; Julie Dechanet-Merville; Jean-Luc Taupin
Journal:  PLoS One       Date:  2013-08-26       Impact factor: 3.240

7.  Analysis of Ig-alpha-tyrosine kinase interaction reveals two levels of binding specificity and tyrosine phosphorylated Ig-alpha stimulation of Fyn activity.

Authors:  M R Clark; S A Johnson; J C Cambier
Journal:  EMBO J       Date:  1994-04-15       Impact factor: 11.598

8.  NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily.

Authors:  C Cantoni; C Bottino; M Vitale; A Pessino; R Augugliaro; A Malaspina; S Parolini; L Moretta; A Moretta; R Biassoni
Journal:  J Exp Med       Date:  1999-03-01       Impact factor: 14.307

9.  Developmental regulation of a mucinlike glycoprotein selectively expressed on natural killer cells.

Authors:  E Vivier; J M Sorrell; M Ackerly; M J Robertson; R A Rasmussen; H Levine; P Anderson
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

10.  Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity.

Authors:  Congcong Zhang; Pranav Oberoi; Sarah Oelsner; Anja Waldmann; Aline Lindner; Torsten Tonn; Winfried S Wels
Journal:  Front Immunol       Date:  2017-05-18       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.